Accolade offers a connected advocacy platform that pairs dedicated Health Assistants and clinicians with an advanced machine‑learning engine, mobile and online messaging, and an integrated benefits center to personalize member experiences. The service drives increased program utilization through member activation campaigns and intelligent insights, coordinating with providers and benefits partners. Accolade reports strong operating metrics in the article, including Net Promoter Scores of 60 and higher, 98% consumer satisfaction ratings, and up to 15% employer cost savings. Its Humana with Accolade offering combines Humana’s provider networks and benefits programs with Accolade’s member engagement services. The companies plan to tailor the joint solution for a broader base of fully insured and ASO prospects and clients, enable robust integrations, and expand geographies in 2020 and beyond. Accolade says it will build out teams needed to support product and market expansion as part of the partnership. Accolade offers a personalized health and benefits solution that combines advisors, clinical experts and intelligent technologies to coordinate care and benefits for employers and health plans. Its technology stack includes the Maya intelligence engine with machine learning, an integrated member portal, the Accolade Mobile app and the Accolade IQ analytics and reporting tool. The company is led by CEO Rajeev Singh and serves more than 1.1 million U.S. employees and their families. Accolade said it will use the new funding to grow its workforce and expand its Personalized Advocacy solution. The platform connects personal health data and programs to present a single point of entry to effective health and benefits resources and coordinates with providers at every step. Accolade provides on-demand healthcare concierge services to employers, health plans and health systems, using a proprietary engagement and influence model to guide consumers through the healthcare system. The company combines data from hundreds of sources with personal insights from relationships between its health assistants and the individuals and families they support. Led by CEO Rajeev Singh and based in Seattle, Accolade emphasizes a data science strategy to personalize consumer interactions. It plans to use the new funding to expand its technology platform, increase R&D, and grow sales and marketing. Financially, the company has been raising a Series E since July 2015 and has secured more than $70m in the current tranche, contributing to a total Series E of more than $90m. Accolade is a cloud-based consumer healthcare engagement and influence platform that helps large self-insured employers and payer organizations guide consumers to providers and care. The platform integrates longitudinal consumer insights and proprietary algorithms to identify individualized care needs, match intervention types, optimize plans of action and personalize outreach across digital, mobile and personal channels. Accolade works with self-insured employers, health systems and health plans. Led by CEO Tom Spann and based in Plymouth Meeting, Pa., the company focuses on improving consumer navigation of healthcare and benefits. The company has announced a strategic funding infusion intended to strengthen its technology and analytics capabilities. The reported financing underscores its focus on expanding product and analytics resources to better serve enterprise customers.

Total raised

$163M

Funding rounds

4

Latest round

Equity

Latest activity

Oct 2019